0001209191-22-036537.txt : 20220613 0001209191-22-036537.hdr.sgml : 20220613 20220613205957 ACCESSION NUMBER: 0001209191-22-036537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stehman-Breen Catherine CENTRAL INDEX KEY: 0001702233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40656 FILM NUMBER: 221013239 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc. CENTRAL INDEX KEY: 0001858848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813789973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-865-2066 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-10 0 0001858848 Tenaya Therapeutics, Inc. TNYA 0001702233 Stehman-Breen Catherine C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLR. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to buy) 5.26 2022-06-10 4 A 0 39727 0.00 A 2023-06-10 2032-06-09 Common Stock 39727 39727 D Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date. /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 2022-06-13 EX-24 2 poa.txt POA DOCUMENT POWER OF ATTORNEY The undersigned, as a Section 16 reporting person of Tenaya Therapeutics, Inc. (the Company), hereby constitutes and appoints Faraz Ali, Leone Patterson and Jennifer Drimmer Rokovich, and each of them, as the true and lawful attorney-in-fact of the undersigned to: 1. complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the ownership, acquisition or disposition of securities of the Company; and 2. do all acts necessary in order to file such forms with the SEC, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate. The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the responsibilities of the undersigned to comply with Section 16 of the Securities Exchange Act of 1934 (as amended). This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June 9, 2022. Signature: /s/ Catherine Stehman-Breen Print Name: Catherine Stehman-Breen